Jo-Anne Young

University of Minnesota

United States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Collaborators (10)

Paschalis Vergidis

Professor of Medicine

UNITED STATES

Daniel Weisdorf

UNITED STATES

Najla El Jurdi

Assistant Professor

University of Minnesota

UNITED STATES

Amir Ahmed Toor

Affiliate Professor

Virginia Commonwealth University

UNITED STATES

Margaret MacMillan

University of Minnesota

UNITED STATES

Tarek Alhamad

Washington University in St. Louis

UNITED STATES

Emily A. Blumberg

UNITED STATES

Carlos A. Gomez

UNITED STATES

Erica J. Stohs

UNITED STATES

Andrea Zimmer

Assistant Professor

University of Nebraska Medical Center

UNITED STATES

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jo-Anne Young

Research Interests

Explore related searches

Contact this professor

Articles (20)

Collaborators (10)

Paschalis Vergidis

Daniel Weisdorf

Najla El Jurdi

Amir Ahmed Toor

Margaret MacMillan

Tarek Alhamad

Emily A. Blumberg

Carlos A. Gomez

Erica J. Stohs

Andrea Zimmer

Make your next move.

Jo-Anne Young

Research Interests

Explore related searches

Contact this professor

Articles (20)

Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection

Letermovir for Prevention of Recurrent Cytomegalovirus in High-Risk Allogeneic Hematopoietic Cell Transplantation Recipients

A Novel Giant Magnetoresistance–Enabled Multiplex Polymerase Chain Reaction Assay for the Diagnosis of Invasive Fungal Infection

Defining and Grading Infections in Clinical Trials Involving Hematopoietic Cell Transplantation: A Report From the BMT CTN Infectious Disease Technical Committee

AURORA

A randomized, placebo‐controlled, dose‐escalation phase I/II multicenter trial of low‐dose cidofovir for BK polyomavirus nephropathy

Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients

SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy

Daily Fungal Cell-Free DNA Testing to Assess Clinical Status during Candida krusei Fungemia

Posoleucel in Kidney Transplant Recipients with BK Viremia

Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

Steroid-Sensitive, but Not Steroid-Dependent or Steroid-Resistant Acute Graft-versus-Host Disease, Results in Similar Infection Risk as No Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation

Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations Are Associated with the Stool Bacterial Microbiome after Hematopoietic Cell Transplantation

Bloodstream Infections in Hematologic Malignancy Patients With Fever and Neutropenia: Are Empirical Antibiotic Therapies in the United States Still Effective?

Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study

Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients

Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus)

2021 Acknowledgment of CMR Reviewers

Aspergillus Infections. Reply

Collaborators (10)

Paschalis Vergidis

Daniel Weisdorf

Najla El Jurdi

Amir Ahmed Toor

Margaret MacMillan

Tarek Alhamad

Emily A. Blumberg

Carlos A. Gomez

Erica J. Stohs

Andrea Zimmer

Make your next move.